A US Food and Drug Administration perspective on evaluating medical products for Ebola.
作者信息
Russek-Cohen Estelle, Rubin Daniel, Price Dionne, Sun Wellington, Cox Edward, Borio Luciana
机构信息
Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA
Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
出版信息
Clin Trials. 2016 Feb;13(1):105-9. doi: 10.1177/1740774515620613. Epub 2016 Jan 14.
PMID:26768565
Abstract
摘要
相似文献
1
A US Food and Drug Administration perspective on evaluating medical products for Ebola.美国食品药品监督管理局对埃博拉医疗产品评估的观点。
Clin Trials. 2016 Feb;13(1):105-9. doi: 10.1177/1740774515620613. Epub 2016 Jan 14.
2
A viewpoint on European Medicines Agency experience with investigational medicinal products for Ebola.关于欧洲药品管理局在埃博拉病毒研究用药品方面经验的观点
Clin Trials. 2016 Feb;13(1):101-4. doi: 10.1177/1740774515619860. Epub 2016 Jan 14.
3
New rules needed to stop the Ebola epidemic.需要新的规则来阻止埃博拉疫情。
Tidsskr Nor Laegeforen. 2014 Oct 14;134(19):1826-7. doi: 10.4045/tidsskr.14.1129.
4
Statistics and logistics: Design of Ebola vaccine trials in West Africa.统计学与后勤保障：西非埃博拉疫苗试验的设计
Clin Trials. 2016 Feb;13(1):87-91. doi: 10.1177/1740774515620612. Epub 2016 Jan 14.
5
Ebola vaccines: keep the clinical trial protocols on the shelf and ready to roll out.埃博拉疫苗：将临床试验方案束之高阁并随时准备推出。
Lancet. 2015 May 9;385(9980):1913-5. doi: 10.1016/S0140-6736(15)60645-6. Epub 2015 Apr 3.
6
As Ebola epidemic begins to slow, trials of drugs and vaccines speed up.随着埃博拉疫情开始放缓，药物和疫苗试验加速推进。
JAMA. 2015 Mar 10;313(10):1000-2. doi: 10.1001/jama.2015.0942.
7
Ethical allocation of drugs and vaccines in the West African ebola epidemic.西非埃博拉疫情中药物和疫苗的伦理分配
Milbank Q. 2014 Dec;92(4):662-6. doi: 10.1111/1468-0009.12089.
8
The year that Ebola virus took over west Africa: missed opportunities for prevention.埃博拉病毒肆虐西非之年：预防工作错失的机遇
Am J Trop Med Hyg. 2015 Feb;92(2):229-232. doi: 10.4269/ajtmh.14-0818. Epub 2015 Jan 5.
9
Ethical challenges posed by the Ebola virus epidemic in West Africa.西非埃博拉病毒疫情引发的伦理挑战。
J Bioeth Inq. 2014 Dec;11(4):417-20. doi: 10.1007/s11673-014-9587-3. Epub 2014 Nov 12.
10
Clinical trials of Ebola vaccine must continue despite fall in number of cases.尽管埃博拉病例数量有所下降，但埃博拉疫苗的临床试验仍须继续。
BMJ. 2015 Feb 17;350:h944. doi: 10.1136/bmj.h944.
引用本文的文献
1
Mathematical modelling for vaccine efficacy trials during the future epidemics of emerging respiratory infections.新发呼吸道感染未来流行期间疫苗效力试验的数学建模
Hum Vaccin Immunother. 2025 Dec;21(1):2467554. doi: 10.1080/21645515.2025.2467554. Epub 2025 Feb 19.
2
The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges.SARS-CoV-2 突变与疫苗效力：新机遇与新挑战。
J Infect Public Health. 2022 Feb;15(2):228-240. doi: 10.1016/j.jiph.2021.12.014. Epub 2022 Jan 5.
3
First vaccine approval under the FDA Animal Rule.美国食品药品监督管理局动物法则下的首个疫苗批准。
NPJ Vaccines. 2016 Aug 25;1:16013. doi: 10.1038/npjvaccines.2016.13. eCollection 2016.
4
The public health value of vaccines beyond efficacy: methods, measures and outcomes.疫苗超出效力之外的公共卫生价值：方法、措施与结果
BMC Med. 2017 Jul 26;15(1):138. doi: 10.1186/s12916-017-0911-8.
Zotero 插件